Ashley L. St. John

Dr. Ashley L. St. John

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
Soman AbrahamSoman Abraham
Soman Abraham
AJAshley L. St. John
Ashley L. St. John

24 January 2019 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
AJAshley L. St. John
Ashley L. St. John
ARAbhay P.S. Rathore
Abhay P.S. Rathore

1 August 2020 in Immunity
Verified
Journal Article
Closed access
IKImmanuel Kwok
Immanuel Kwok
EBEtienne Becht
Etienne Becht
YXYu Xia
Yu Xia
MNMelissa Ng
Melissa Ng
YTYe Chean Teh
Ye Chean Teh
LNLai Guan Ng
Lai Guan Ng

24 October 2006 in Blood
Verified
Journal Article
Open access
PDF file
IDIvan Dzhagalov
Ivan Dzhagalov
AJAshley L. St. John
Ashley L. St. John
YHYou-Wen He
You-Wen He
The antiapoptotic protein Mcl-1, a member of the Bcl-2 family, plays critical roles in promoting the survival of lymphocytes and hematopoietic stem cells. Although previous studies have implicated Mcl-1 in regulating the survival of neutrophils and macrophages, the in vivo function of Mcl-1 in these 2 cell lineages remained unclear. To address this, we have generated mice conditionally lacking Mcl-1 expression in neutrophils and macrophages. We show that Mcl-1 conditional knockout mice had a severe defect in neutrophil survival, whereas macrophage survival was normal. The granulocyte compartment in the blood, spleen, and bone marrow of Mcl-1 conditional knockout mice exhibited an approximately 2- to 3-fold higher apoptotic rate than control cells. In contrast, resting and activated macrophages from Mcl-1–deficient mice exhibited normal survival and contained up-regulated expression of Bcl-2 and Bcl-xL. These data suggest that Mcl-1 plays a nonredundant role in promoting the survival of neutrophils but not macrophages.

17 November 2011 in Blood
Verified
Journal Article
Open access
PDF file
CKChristian A. Kunder
Christian A. Kunder
AJAshley L. St. John
Ashley L. St. John
SASoman N. Abraham
Soman N. Abraham
Mast cells (MCs) promote a wide range of localized and systemic inflammatory responses. Their involvement in immediate as well as chronic inflammatory reactions at both local and distal sites points to an extraordinarily powerful immunoregulatory capacity with spatial and temporal versatility. MCs are preferentially found in close proximity to both vascular and lymphatic vessels. On activation, they undergo a biphasic secretory response involving the rapid release of prestored vasoactive mediators followed by de novo synthesized products. Many actions of MCs are related to their capacity to regulate vascular flow and permeability and to the recruitment of various inflammatory cells from the vasculature into inflammatory sites. These mediators often work in an additive fashion and achieve their inflammatory effects locally by directly acting on the vascular and lymphatic endothelia, but they also can affect distal sites. Along these lines, the lymphatic and endothelial vasculatures of the host act as a conduit for the dissemination of MC signals during inflammation. The central role of the MC-endothelial cell axis to immune homeostasis is emphasized by the fact that some of the most effective current treatments for inflammatory disorders are directed at interfering with this interaction.

26 February 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ARAbhay P.S. Rathore
Abhay P.S. Rathore
AJAshley L. St. John
Ashley L. St. John
Flaviviruses consist of significant human pathogens responsible for hundreds of millions of infections each year. Their antigenic relationships generate immune responses that are cross-reactive to multiple flaviviruses and their widespread and overlapping geographical distributions, coupled with increases in vaccination coverage, increase the likelihood of exposure to multiple flaviviruses. Depending on the antigenic properties of the viruses to which a person is exposed, flavivirus cross-reactivity can be beneficial or could promote immune pathologies. In this review we describe our knowledge of the functional immune outcomes that arise from varied flaviviral immune statuses. The cross-reactive antibody and T cell immune responses that are protective versus pathological are also addressed.